Kazia Therapeutics (KZIA) Tax Provisions (2009 - 2011)

Kazia Therapeutics (KZIA) has 3 years of Tax Provisions data on file, last reported at -$6066.3 in Q4 2011.

• In Q4 2011, Tax Provisions rose 38.58% year-over-year to -$6066.3; the TTM figure through Dec 2011 stood at $2.4 million (down 63.22% YoY), while the FY2025 annual figure was -$1.1 million, down 526.11% from the prior year.
• Tax Provisions improved to -$6066.3 in Q4 2011, from -$9876.1 in the prior quarter.
• Across five years, Tax Provisions topped out at -$908.95 in Q4 2009 and bottomed at -$9876.1 in Q4 2010.
• A 3-year average of -$5617.1 and a median of -$6066.3 in 2011 frame the typical range for Tax Provisions.
• Annual changes were most pronounced in 2010 — Tax Provisions sank 986.53% — and 2011, when it jumped 38.58%.
• Year by year, Tax Provisions stood at -$908.95 in 2009, then sank by 986.53% to -$9876.1 in 2010, then jumped by 38.58% to -$6066.3 in 2011.
• The last three Tax Provisions figures came in at -$6066.3 (Q4 2011), -$9876.1 (Q4 2010), and -$908.95 (Q4 2009), per Business Quant data.

Peer Comparison